|
Volumn 56, Issue 1, 2004, Pages 101-106
|
Effects of chronic administration of PL017 and beta-funaltrexamine hydrochloride on susceptibility of kainic acid-induced seizures in rats.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA FUNALTREXAMINE;
BETA-FUNALTREXAMINE;
DRUG DERIVATIVE;
DYNORPHIN;
KAINIC ACID;
MU OPIATE RECEPTOR;
NALTREXONE;
PEPTIDE FRAGMENT;
PL017 DYNORPHIN A (6 17);
PL017-DYNORPHIN A (6-17);
ANIMAL;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DISEASE PREDISPOSITION;
DRUG ANTAGONISM;
DRUG POTENTIATION;
EPILEPSY;
HIPPOCAMPUS;
MALE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RAT;
SPRAGUE DAWLEY RAT;
ANIMALS;
DISEASE SUSCEPTIBILITY;
DYNORPHINS;
EPILEPSY;
HIPPOCAMPUS;
KAINIC ACID;
MALE;
NALTREXONE;
PEPTIDE FRAGMENTS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, OPIOID, MU;
|
EID: 3142777794
PISSN: 03710874
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|